Therefore, this research aimed to determine the potential of RCAN3 as a diagnostic and prognostic biomarker in pan-cancer studies and as a molecular target for addressing cervical squamous cell carcinoma and endocervical adenocarcinoma cervical cancer (CESC). The gene discussed is RCAN3; the disease is cancer.